QBIO Insider Trading Activity and SEC Form 4 Filings
QBIO insider trading summary
No open-market insider purchases or sales of Q BioMed Inc. (QBIO) have been reported on SEC Form 4 in the past 12 months.
Latest QBIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jul 12, 2018 | Denis Corin | Chief Executive Officer | Sell | $14K (6,400 @ $2.11) |
| Jul 10, 2018 | Denis Corin | Chief Executive Officer | Sell | $20K (7,000 @ $2.85) |
| Jul 9, 2018 | Denis Corin | Chief Executive Officer | Sell | $24K (7,000 @ $3.37) |
| Jul 6, 2018 | Denis Corin | Chief Executive Officer | Sell | $25K (6,900 @ $3.58) |
| Jul 5, 2018 | Denis Corin | Chief Executive Officer | Sell | $23K (6,600 @ $3.54) |
| Jul 3, 2018 | Denis Corin | Chief Executive Officer | Sell | $8K (2,200 @ $3.46) |
| Jul 2, 2018 | Denis Corin | Chief Executive Officer | Sell | $7K (2,000 @ $3.42) |
| Jun 29, 2018 | Denis Corin | Chief Executive Officer | Sell | $7K (2,100 @ $3.40) |
| Jun 28, 2018 | Denis Corin | Chief Executive Officer | Sell | $18K (5,300 @ $3.39) |
| Jun 27, 2018 | Denis Corin | Chief Executive Officer | Sell | $17K (4,900 @ $3.44) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.